Authors: Xie Zhenggao, Chen Fang, Zhu Jun, Du Wei, Chen Xi, Gan Chunlan DOI: 10.3760/cma.j.issn.2095-0160.2015.12.013 Published 2015-12-10 Cite as Chin J Exp Ophthalmol, 2015,33(12): 1113-1117. Abstract [Download PDF] [Read Full Text] Background Pars plana vitrectomy (PPV) is a main method of […]
Tag: monoclonal
Influence factors and strategies of anti-VEGF therapy for wet AMD
Authors: Dai Hong, Lu Yingyi DOI: 10.3760/cma.j.issn.2095-0160.2016.01.001 Published 2016-01-10 Cite as Chin J Exp Ophthalmol, 2016,34(1): 1-4. Abstract [Download PDF] [Read Full Text] Neovascular age-related macular degeneration is also known as wet age-related macular degeneration (wAMD), which is now one of potentially blinding diseases in elder population worldwide.The […]
Macular choroidal thickness changes following intravitreal injection of ranibizumab for central retinal vein occlusion
Authors: Du Yuqin, Han Mei, Xie Shiyong, Wang Ying, Li Yan DOI: 10.3760/cma.j.issn.2095-0160.2016.01.016 Published 2016-01-10 Cite as Chin J Exp Ophthalmol, 2016,34(1): 72-77. Abstract [Download PDF] [Read Full Text] Background Central retinal vein occlusion (CRVO) is a common retinal vascular disease.Intravitreal injection of ranibizumab, a vascular endothelial growth factor (VEGF) […]
The relationship between central retinal thickness relative change and visual prognosis in diabetic macular edema patients following intravitreal injection of ranibizumab
Authors: Han Yuesheng, Wei Wenbin DOI: 10.3760/cma.j.issn.2095-0160.2016.01.017 Published 2016-01-10 Cite as Chin J Exp Ophthalmol, 2016,34(1): 78-84. Abstract [Download PDF] [Read Full Text] Background The studies on intravitreal ranibizumab for diabetic macular edema (DME) primarily focuses on the absolute change of central retinal thickness, while the affection of […]
A comparative study on conbercept and triamcinolone acetoinde intravitreal injection for macular edema secondary to central retinal vein occlusion
Authors: Ma Fengwei, Du Cuiyun, Cheng Meihong, Ma Yusheng DOI: 10.3760/cma.j.issn.2095-0160.2016.09.013 Published 2016-09-10 Cite as Chin J Exp Ophthalmol, 2016,34(9): 837-841. Abstract [Download PDF] [Read Full Text] Background Macular edema is one of the serious complications of central retinal vein occlusion (CRVO), and the present therapies are laser coagulation […]
Inhibitory effects of bevacizumab on filtering bleb scarring following trabeculectomy in rabbits
Authors: Liang Pei, Yang Jin, Lin Jinyong DOI: 10.3760/cma.j.issn.2095-0160.2016.07.004 Published 2016-07-10 Cite as Chin J Exp Ophthalmol, 2016,34(7): 591-596. Abstract [Download PDF] [Read Full Text] Background The primary reason to trabeculectomy failure is fibrosis of conjunctiva and episclera because of progressive fibroblast proliferation and collagen deposition […]
Therapeutic efficacy and significance of intravitreal injection of ranibizumab for age-related macular degeneration with subfoveal scarring and active lesion
Authors: Li Juanjuan, Li Hua DOI: 10.3760/cma.j.issn.2095-0160.2017.01.009 Published 2017-01-10 Cite as Chin J Exp Ophthalmol, 2017,35(1): 42-46. Abstract [Download PDF] [Read Full Text] Background Intravitreal injection of ranibizumab is a primary approach to the treatment of wet age-related macular degeneration (wAMD), but whether it is necessary for […]
Influence of repetitive intravitreal ranibizumab for neovascular age-related macular degeneration on retinal pigment epithelium and choroidal thickness
Authors: Qi Hang, Chen Changzheng, Su Yu, Yi Zuohuizi DOI: 10.3760/cma.j.issn.2095-0160.2017.10.012 Published 2017-10-10 Cite as Chin J Exp Ophthalmol, 2017,35(10): 909-913. Abstract [Download PDF] [Read Full Text] Background Intravitreal injection of ranibizumab (IVR) is one of the most effective therapies for neovascular age-related macular degeneration (nAMD). Understanding the influence […]